Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
25
27
28
29
1
3
5
6
7
8
11
13
15
17
18
19
20
21
22
24
25
27
28
29
31
1
2
3
4
5
3rd International conference on  Diabetes, Hypertension and Metabolic Syndrome
2020-02-24 - 2020-02-25    
All Day
About Diabetes Meet 2020 Conference Series takes the immense Pleasure to invite participants from all over the world to attend the 3rdInternational conference on Diabetes, Hypertension and [...]
3rd International Conference on Cardiology and Heart Diseases
2020-02-24 - 2020-02-25    
All Day
ABOUT 3RD INTERNATIONAL CONFERENCE ON CARDIOLOGY AND HEART DISEASES The standard goal of Cardiology 2020 is to move the cardiology results and improvements and to [...]
Medical Device Development Expo OSAKA
2020-02-26 - 2020-02-28    
All Day
ABOUT MEDICAL DEVICE DEVELOPMENT EXPO OSAKA What is Medical Device Development Expo OSAKA (MEDIX OSAKA)? Gathers All Kinds of Technologies for Medical Device Development! This [...]
Beauty Care Asia Pacific Summit 2020 (BCAP)
2020-03-02 - 2020-03-04    
All Day
Groundbreaking Event to Address Asia-Pacific’s Growing Beauty Sector—Your Window to the World’s Fastest Growing Beauty Market The international cosmetics industry has experienced a rapid rise [...]
IASTEM - 789th International Conference On Medical, Biological And Pharmaceutical Sciences ICMBPS
2020-03-04 - 2020-03-05    
All Day
IASTEM - 789th International Conference on Medical, Biological and Pharmaceutical Sciences ICMBPS will be held on 4th - 5th March, 2020 at Hamburg, Germany . [...]
Global Drug Delivery And Formulation Summit 2020
2020-03-09 - 2020-03-11    
All Day
Innovative solutions to the greatest challenges in pharmaceutical development. Price: Full price delegate ticket: GBP 1495.0. Time: 9:00 am to 6:00 pm About Conference KC [...]
Inborn Errors Of Metabolism Drug Development Summit 2020
2020-03-10 - 2020-03-12    
All Day
Confidently Translate, Develop and Commercialize Gene, mRNA, Replacement Therapies, Small Molecule and Substrate Reduction Therapies to More Efficaciously Treat Inherited Metabolic Diseases. Time: 8:00 am [...]
Texting And E-Mail With Patients: Patient Requests And Complying With HIPAA
2020-03-12    
All Day
Overview:  This session will focus on the rights of individuals to communicate in the manner they desire, and how a medical office can decide what [...]
14 Mar
2020-03-14 - 2020-03-21    
All Day
Topics in Family Medicine, Hematology, and Oncology CME Cruise. Prices: USD 495.0 to USD 895.0. Speakers: David Parrish, MS, MD, FAAFP, Alexander E. Denes, MD, [...]
International Conference On Healthcare And Clinical Gerontology ICHCG
2020-03-14 - 2020-03-15    
All Day
An elegant and rich premier global platform for the International Conference on Healthcare and Clinical Gerontology ICHCG that uniquely describes the Academic research and development [...]
World Congress And Expo On Cell And Stem Cell Research
2020-03-16 - 2020-03-17    
All Day
"The world best platform for all the researchers to showcase their research work through OralPoster presentations in front of the international audience, provided with additional [...]
25th International Conference on  Diabetes, Endocrinology and Healthcare
2020-03-23 - 2020-03-24    
All Day
About Conference: Conference Series LLC Ltd is overwhelmed to announce the commencement of “25th International Conference on Diabetes, Endocrinology and Healthcare” to be held during [...]
ISN World Congress of Nephrology 2020
2020-03-26 - 2020-03-29    
All Day
ABOUT ISN WORLD CONGRESS OF NEPHROLOGY 2020 ISN World Congress of Nephrology (WCN) takes place annually to enable this premier educational event more available to [...]
30 Mar
2020-03-30 - 2020-03-31    
All Day
This Cardio Diabetes 2020 includes Speaker talks, Keynote & Poster presentations, Exhibition, Symposia, and Workshops. This International Conference will help in interacting and meeting with diabetes and [...]
Trending Topics In Internal Medicine 2020
2020-04-02 - 2020-04-04    
All Day
Trending Topics in Internal Medicine is a CME course that will tackle the latest information trending in healthcare today.   This course will help you discuss options [...]
2020 Summit On National & Global Cancer Health Disparities
2020-04-03 - 2020-04-04    
All Day
The 2020 Summit on National & Global Cancer Health Disparities is planned with the goal of creating a momentum to minimize the disparities in cancer [...]
Events on 2020-02-26
Events on 2020-03-02
Events on 2020-03-09
Events on 2020-03-10
Events on 2020-03-16
Events on 2020-03-26
Events on 2020-03-30
Events on 2020-04-02
Events on 2020-04-03
Articles

Oct 18: EHR market in flux as Stage 2 of Meaningful Use approaches

ehr interoperability

Stage 2 of the EHR Incentive Program is about to heat up healthcare, imposing more stringent requirements on providers and vendors alike.  With the top seat at the ONC still open and the 2014 certification process creeping along, there are deep concerns within the industry about the feasibility of proceeding with Stage 2 on the current timetable.  Lauren Fifield, Senior Health Policy Advisor at Practice Fusion, sat down with EHRintelligence to discuss how the upcoming changes will impact the EHR market as we move forward with meaningful use.

What are your bets for the new National Coordinator?
I guess it’s sort of defaulted to Jacob Reider, following David Muntz’s decision to leave as well.  Jacob is one of my bets.  He comes from the private sector, so he understands what it means to be an EHR vendor.  He’s a provider, and he’s done pretty well in negotiating the public sector and driving change.  So he’s definitely a top pick.  I’m a huge fan of Dr. Theresa Cullen.  She started at the Indian Health Service and is now at the VA, running the health IT division.
Some of the others may be some of the more well-known figures in health IT, like John Halamka or Micky Tripathi.  I think they could do well, but there’s something to be said for someone who’s had experience navigating the public sector, because it moves differently.  You need someone who’s been in the field, boots on the ground, and honestly, is willing to sign up for a few years of punishment.  It’ll be interesting to see.
Do you think there will be a delay to Stage 2 of meaningful use?
I don’t think there will be a delay.  I do think there’s a percentage chance – not a hundred percent, but there is a chance that there will be an extension of the reporting for year one of Stage 2.  Providers might be able to attest into 2015, so that those providers who are ready don’t get penalized, kind of, for being ready, and there isn’t that sort of industry pull-back like we saw with ICD-10.  Folks had invested money, and vendors had gotten onto this “should we, shouldn’t we” track.  I think there’s probably a 30 or 40 percent chance of an extension.
The 2014 meaningful use certification process has been moving very slowly.  How will that affect the market as we move into Stage 2?
I think only about 10 percent of vendors have gotten certified for Stage 2.  That’s not a terrible surprise, all things considered.  Stage 2 definitely ups the ante, and the 2014 requirements are pretty significant.  I think a lot of vendors are trying to also develop things in parallel to keep up with different payment models, and ACOs, and different initiatives like ICD-10.  They’re trying to develop data analytics platforms and things like that.  So I’m not terribly surprised.  Come January or February, I think it’ll be more of a tell-tale sign.
But I think that the fact that some vendors win and lose is also a good thing for the market.  For Stage 1, only about 50% of vendors had one or more attestations, and 50% of vendors had no one.  It’ll be an interesting question to see if what’s good for the market will also be good for providers.  Meaningful use has done an amazing thing when it comes to standards and forming consensus around the need for exchange and patient engagement, but I do think that having the government create a set of requirements has driven a wedge between vendors and users.
Other markets run on the fact that users need X, and good vendors create X.  The better value they create, the better it is for the market.  But when the government is saying “user needs X”, things get a little bit distorted.  I don’t know what kind of market the EHR field will be as long as meaningful use is present.
The EHR replacement market keeps growing.  What’s your advice to providers who are looking for a replacement system?
The replacement trend is a good one, in that hopefully it means that providers have bought on to use of the EHR enough so that they’re actually considering business drivers which maybe the first time around they didn’t really consider.  So I think it can be a good thing.  There will definitely be some logistics to figure out in terms of transferring large amounts of complex data to a new system, but if it means that physicians are getting to address business needs and clinical needs better, then I think it’s great.
You need to be thinking like a business person when you’re signing on the dotted line.  Or you need to make sure that part of your practice team includes someone that’s going to handle that business side, and can manage things like contracts and acquisition of tools and use of technology.  I get it that a doctor doesn’t want to read a contract.  It’s not their skill set.  But you need to make sure that someone is doing that.